Erik Davis says: I recently published my first column for Aeon Magazine's online site, a "post-secular" take on the current wave of psychedelic research. Without plunging into woo, the article attempts to chart the liminal zones that lie beyond brain-based reductionism. It seemed a good piece for Aeon, a new British outfit that is charting a very interesting zone between science, religion, culture, and good writing.
Studies recently carried out at Yale, and published last month in the journal Science, have confirmed earlier reports that ketamine offers remarkable, nearly instantaneous relief for people who suffer from forms of major depression impervious to other treatment methods. Interpreting depression as a hardware problem largely caused by the loss of synaptic connections, the researchers argue that ketamine works by encouraging sprightly neural growth in brain regions correlated with memory and mood. Journalistic reports also linked this research with the development of a new vein of antidepressants, including Naurex’s GLYX-13, that have the neurone-fertilising power of ketamine without, as one report describes them, the ‘schizophrenia-like effects’.
Rarely has the new neuro-reductionism been so naked in its repackaging of human experience. Nowhere in the research or the journalism does anyone suggest that heavily depressed people feel better because ketamine sends them on a first-person voyage through profound, sometimes ecstatic, and certainly mind-bending modes of transpersonal consciousness whose subjective power might itself boot the mind out of its most mirthless ruts.
Return trip: A new generation of researchers is heading into the weird world of psychedelic drugs. It could change their minds
Nature Magazine reports that researchers from Imperial College London gave psilocybin to 12 people with depression. All the patients showed “a marked improvement in their symptoms.” From Nature: Researchers from Imperial College London gave 12 people psilocybin, the active component in magic mushrooms. All had been clinically depressed for a significant amount of time — […]
This 61-year-old woman, who has never taken psychedelics before, decided to take 1 gram of psilocybe cubensis (a very small dose). In this video, shot by her son, we get to watch her go through the different stages of what seems to be a fairly strong trip, which lasts about four hours. She said she […]
Jean Francois Painchaud, aka PHAZED, is Canadian animator/producer who works on the PBS kids show, Wild Kratts. He also makes trippy, NSFW Gifs and posts them to his accounts on Twitter, Instagram, Tumblr and Facebook. Shogofawafa recently interviewed PHAZED about his work, and how he deals with the censorious bluenoses at Facebook. Your work became […]
Every company wants to harness the power of social media, but few understand how to make that happen. Be one of those select few with this Social Media Marketing Course & Certification package, now just $29 in the Boing Boing Store.Over 12 modules of course material, you’ll learn what it takes to increase a brand’s […]
If you’ve got a killer app idea, but don’t have the technical expertise to pull it off, get a crash course in all things app development with the Comprehensive Android Development Bundle, now over 90% off in the Boing Boing Store. Across 83 hours of training, you’ll learn to develop for the world’s most popular mobile OS, mastering […]
Jared Sinclair developed the RSS reader app Unread, which made $10,000 in its first 24 hours on the iOS market. And we’ve all heard the story of Flappy Bird developer Dong Nguyen, whose creation was reportedly earning $50,000 a day at the height of its 2013 explosion. While those are rare examples, they’re also testament to the […]